FDA Accepts Supplemental Biologics License Application for Genentech’s Lunsumio and Polivy Combination for People With Relapsed or Refractory Large B-Cell Lymphoma

Go back to FDA Accepts Supplemental Biologics License Application for Genentech’s Lunsumio and Polivy Combination for People With Relapsed or Refractory Large B-Cell Lymphoma
Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 53.54 -0.53 (0.98%)
Previous Close $54.07    52 Week High $35.13 
Open $54.07    52 Week Low $28.10 
Day High $54.29    P/E N/A 
Day Low $53.48    EPS $0.00 
Volume 467,716       

Brown & Brown, Inc. (NYSE: RO) Delayed: 8.49 +0.55 (6.93%)
Previous Close $7.94    52 Week High $8.59 
Open $7.94    52 Week Low $7.82 
Day High $8.59    P/E 6.53 
Day Low $7.82    EPS $1.30 
Volume 42,732       

Roper Industries (NASDAQ: ROP) Delayed: 392.01 -3.64 (0.92%)
Previous Close $395.65    52 Week High $195.93 
Open $395.53    52 Week Low $155.79 
Day High $396.78    P/E 73.00 
Day Low $388.21    EPS $5.37 
Volume 74,983